News

FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body
By Lori Solomon HealthDay ReporterTUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Medscape5d
FDA Expands Approval of Roflumilast Foam for Treating Scalp, Body Psoriasis
The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...
Healio5d
FDA approves Zoryve foam 0.3% for scalp, body psoriasis
The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...
MPR13h
Zoryve Foam 0.3% Approved for Plaque Psoriasis of the Scalp, Body
The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...
Belly fat ‘may cause burning and painful skin condition’ suffered by Kim Kardashian – how to shift the pounds
BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...
The American Journal of Managed Care5d
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis
Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...
Hair botox, keratin, nanoplastia: Tips on choosing the right smoothening treatment for your hair type
Hair care expert on the smoothening treatment your scalp might secretly hate and the one that's right for your hair type.
GlobalData on MSN6d
Accropeutics’ TYK2/JAK1 inhibitor meets endpoints in Phase II psoriasis trial
Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...
Tribune Online on MSN1h
Common household items that aid cleaning
Keeping the house clean is a source of concern to many, especially with the rising cost of cleaning reagents. It is however ...